Does Sensitive Cyp3a Substrates Interact with Suzetrigine?
Sensitive Cyp3a Substrates and Suzetrigine have a moderate drug interaction according to U.S. FDA drug labeling data. Dosage modification of sensitive CYP3A substrates may be required when initiating or discontinuing JOURNAVX. JOURNAVX is a CYP3A inducer that may reduce exposure of CYP3A substrates. The mechanism involves suzetrigine is a cyp3a inducer that reduces exposure of sensitive cyp3a substrates. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Suzetrigine Class
- Sodium Channel Blocker
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Sensitive Cyp3a Substrates and Suzetrigine occurs because suzetrigine is a cyp3a inducer that reduces exposure of sensitive cyp3a substrates. Clinically, this means dosage modification of sensitive cyp3a substrates may be required when initiating or discontinuing journavx. journavx is a cyp3a inducer that may reduce exposure of cyp3a substrates. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Sensitive Cyp3a Substrates and your doctor is considering prescribing Suzetrigine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider